Moreover, the expressions of IL-1β and Arg-1 decreased more obviously in cEVs-treated hearts than that receiving nEVs treatment, indicating that cEVs treatment showed better efficiency in modulating the cardiac inflammatory response post infarction. The gene discussed is IL1B; the disease is infarction.